These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 30464460)
1. Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy. Cheng WJ; Chen LC; Ho HO; Lin HL; Sheu MT Int J Nanomedicine; 2018; 13():7079-7094. PubMed ID: 30464460 [TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing. Teo PY; Yang C; Whilding LM; Parente-Pereira AC; Maher J; George AJ; Hedrick JL; Yang YY; Ghaem-Maghami S Adv Healthc Mater; 2015 Jun; 4(8):1180-9. PubMed ID: 25866054 [TBL] [Abstract][Full Text] [Related]
3. A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids. Wen J; Qiu N; Zhu Z; Bai P; Hu M; Qi W; Liu Y; Wei A; Chen L Drug Deliv; 2021 Dec; 28(1):1055-1066. PubMed ID: 34078185 [TBL] [Abstract][Full Text] [Related]
4. Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9. Hosseini ES; Nikkhah M; Hosseinkhani S Int J Nanomedicine; 2019; 14():4353-4366. PubMed ID: 31354265 [No Abstract] [Full Text] [Related]
5. Polyethylenimine based magnetic nanoparticles mediated non-viral CRISPR/Cas9 system for genome editing. Rohiwal SS; Dvorakova N; Klima J; Vaskovicova M; Senigl F; Slouf M; Pavlova E; Stepanek P; Babuka D; Benes H; Ellederova Z; Stieger K Sci Rep; 2020 Mar; 10(1):4619. PubMed ID: 32165679 [TBL] [Abstract][Full Text] [Related]
6. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer. Luo X; Peng X; Hou J; Wu S; Shen J; Wang L Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626 [TBL] [Abstract][Full Text] [Related]
7. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model. Ben David-Naim M; Grad E; Aizik G; Nordling-David MM; Moshel O; Granot Z; Golomb G Biomaterials; 2017 Nov; 145():154-167. PubMed ID: 28863309 [TBL] [Abstract][Full Text] [Related]
8. Novel PEI/Poly-γ-Gutamic Acid Nanoparticles for High Efficient siRNA and Plasmid DNA Co-Delivery. Peng SF; Hsu HK; Lin CC; Cheng YM; Hsu KH Molecules; 2017 Jan; 22(1):. PubMed ID: 28054985 [TBL] [Abstract][Full Text] [Related]
9. Investigation of siRNA-loaded polyethylenimine-coated human serum albumin nanoparticle complexes for the treatment of breast cancer. Abbasi S; Paul A; Prakash S Cell Biochem Biophys; 2011 Nov; 61(2):277-87. PubMed ID: 21556941 [TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches. Won JE; Byeon Y; Wi TI; Lee CM; Lee JH; Kang TH; Lee JW; Lee Y; Park YM; Han HD J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35228265 [TBL] [Abstract][Full Text] [Related]
11. Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells. Hasanpoor Z; Mostafaie A; Nikokar I; Hassan ZM Int J Biol Macromol; 2020 Sep; 159():137-153. PubMed ID: 32335119 [TBL] [Abstract][Full Text] [Related]
12. PD-L1 siRNA hitched polyethyleneimine-elastase constituting nanovesicle induces tumor immunogenicity and PD-L1 silencing for synergistic antitumor immunotherapy. Du L; Gong Y; Zhang X; Sun J; Gao F; Shen M; Bai H; Yang T; Cheng X; Li S; Peng J; Liu Z; Ding S; Chen J; Cheng W J Nanobiotechnology; 2024 Jul; 22(1):442. PubMed ID: 39068444 [TBL] [Abstract][Full Text] [Related]
13. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery. Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593 [TBL] [Abstract][Full Text] [Related]
14. Silencing of GFP expression in human mesenchymal stem cells using quaternary polyplexes of siRNA-PEI with glycosaminoglycans and albumin. Herrera LC; Shastri VP Acta Biomater; 2019 Nov; 99():397-411. PubMed ID: 31541736 [TBL] [Abstract][Full Text] [Related]
15. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells. Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439 [TBL] [Abstract][Full Text] [Related]
16. Amphiphilic core-shell nanoparticles containing dense polyethyleneimine shells for efficient delivery of microRNA to Kupffer cells. Liu Z; Niu D; Zhang J; Zhang W; Yao Y; Li P; Gong J Int J Nanomedicine; 2016; 11():2785-97. PubMed ID: 27366061 [TBL] [Abstract][Full Text] [Related]
17. Small hydrophobe substitution on polyethylenimine for plasmid DNA delivery: Optimal substitution is critical for effective delivery. Thapa B; Plianwong S; Remant Bahadur KC; Rutherford B; Uludağ H Acta Biomater; 2016 Mar; 33():213-24. PubMed ID: 26802444 [TBL] [Abstract][Full Text] [Related]
18. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes. Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390 [TBL] [Abstract][Full Text] [Related]
19. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing. Tan YF; Mundargi RC; Chen MH; Lessig J; Neu B; Venkatraman SS; Wong TT Small; 2014 May; 10(9):1790-8. PubMed ID: 24510544 [TBL] [Abstract][Full Text] [Related]
20. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier. Wang J; Dou B; Bao Y Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]